MedEd On The Go - Short-Form Comprehensive Medical Education > Cardiology > events

A CME-Certified Breakfast Symposium

Breaking Through the Resistance - Innovations Surrounding Resistant Hypertension

A CME-Certified Breakfast Symposium

Saturday, November 5, 2022
6:00am – 7:30am CT
Chicago, IL

Marriott Marquis Chicago
2121 South Prairie Avenue, Chicago, IL 60616
Great Lakes AB Room, 2nd Floor

Breakfast will be provided

This event has concluded. Thank you to all who presented and attended. This symposium, including downloadable slides, will soon be available on-demand at MedEd On The Go.

This event is not part of the official Scientific Sessions as planned by the AHA Committee on Scientific Sessions Programming.

Symposium Overview

When patients present with resistant hypertension, clinicians aim to stabilize blood pressure by adding or replacing traditional agents, then hope that noncompliance and reduced adherence won’t further complicate management. Fortunately, new and effective pharmacologic treatments, device therapies and multidisciplinary team approaches are rapidly changing outcomes. This CME-certified symposium will assess diagnostic delay consequences, traditional treatment shortfalls, dual endothelin-receptor antagonists and why guidelines don’t keep pace with real-world clinical practice.

Chair

Sreekanth Vemulapalli, MD

Assistant Professor of Medicine, Division of Cardiology
Duke University School of Medicine
Durham, NC

Faculty

George L. Bakris, MD

Professor of Medicine
Director, Am. Heart Assoc. Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, IL

Keith C. Ferdinand, MD

Gerald S. Berenson Endowed Chair in Preventive Cardiology
Professor of Medicine
Tulane University School of Medicine
New Orleans, LA

Raven Voora, MD

Associate Professor of Medicine
University of North Carolina, Division of Nephrology and Hypertension
Chapel Hill, NC

Full Accreditation and Program Information

Agenda

6:00am

–

Registration & Breakfast

6:15am

–

Welcome & Introductions

6:20am

–

What are the “Faces” of Resistant Hypertension? – Dr. Voora

6:30am

–

What Do Our Latest Guidelines Recommend? – Dr. Bakris

6:37am

–

Panel Discussion: How Do We Apply These Practices Locally?

6:44am

–

New Modalities and MOAs for Resistant Hypertension? – Dr. Vemulapalli

6:54am

–

Panel Discussion: Does the PRECISION Trial Change the Landscape of Resistant Hypertension?

7:04am

–

Should We Be Resistant to Newer Therapies on the Horizon? – Dr. Ferdinand

7:19am

–

Panel Discussion: Bringing It All Together – How to Manage Our “Faces”?

7:30am

–

Adjourn

Target Audience

This activity has been designed to meet the educational needs of the interprofessional team, including cardiologists, nurse practitioners, physician assistants, nurses, and pharmacists, involved in the management of patients with resistant hypertension.

Learning Objectives

After completing this activity, the participant should be better able to:

Identify appropriate patients with a diagnosis of resistant hypertension, in the presence of various comorbidities and inequities in healthcare
Apply the latest evidence-based approaches to prevent diagnostic delays and maximize management prognostic outcomes for resistant hypertension
Demonstrate the role of current guidelines and their application to current clinical practice patterns in addressing the management of resistant hypertension
Understand emerging data of classes and mechanisms of drugs, with a focus on adherence, combinations, and compliance of pharmacological treatments in controlling resistant hypertension

Accreditation Information

Joint Accreditation Statement
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and TotalCME, Inc. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.

Fee Information: There is no fee for this educational activity.

Participants will receive an email after the event with a link to complete the evaluation form. Completion of the evaluation form will allow for credit to be processed and emailed to the participant.

This activity is supported by an independent educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC
Jointly provided by Global Learning Collaborative (GLC), Duke Heart, and TotalCME, Inc.